News | Gyrolab® Immunoassay Solutions | Gyros Protein Technologies

02/05/2025

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

11/28/2024

A workplace that attracts

06/18/2024

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

05/09/2024

Regarding transfer of Gyros Protein Technologies headquarter to a new facility

05/02/2024

Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment

03/27/2024

Gyros Protein Technologies Introduces New Gyrolab CRO Certification Program for Qualifying CRO Partners

09/20/2023

Celebrating 20 years of a remarkable Gyrolab journey!

05/02/2023

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

11/29/2022

Gyros Protein Technologies adds Gyrolab® Biomarker Kits to expand range of ready-to-use kits and reagents

09/30/2021

Gyros Protein Technologies introduces Gyrolab AAV9 Titer Kit to support AAV-based cell and gene therapy production

07/07/2021

Gyros Protein Technologies and Cygnus Technologies introduce HEK 293 HCP Solution for Gyrolab

01/27/2021

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

09/02/2020

Gyros Protein Technologies introduces Gyrolab AAVX Titer Kit to support cell and gene therapy market

03/16/2020

Gyrolab Technology to be incorporated into Jefferson Institute for bioprocessing specialized teaching curriculum and training programs

12/05/2019

VolitionRx and Gyros Protein Technologies awarded an aggregate $1 million+ Eurostars cash grant to collaborate on developing a lung cancer blood test

10/31/2019

Mesa Labs acquires Gyros Protein Technologies

09/09/2019

Gyros Protein Technologies introduces Gyrolab p24 Kit to support the cell and gene therapy market

06/13/2019

Topic

Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development

A workplace that attracts

Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development

Regarding transfer of Gyros Protein Technologies headquarter to a new facility

Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment

Gyros Protein Technologies Introduces New Gyrolab CRO Certification Program for Qualifying CRO Partners

Celebrating 20 years of a remarkable Gyrolab journey!

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Gyros Protein Technologies adds Gyrolab® Biomarker Kits to expand range of ready-to-use kits and reagents

Gyros Protein Technologies introduces Gyrolab AAV9 Titer Kit to support AAV-based cell and gene therapy production

Gyros Protein Technologies and Cygnus Technologies introduce HEK 293 HCP Solution for Gyrolab

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

Gyros Protein Technologies introduces Gyrolab AAVX Titer Kit to support cell and gene therapy market

Gyrolab Technology to be incorporated into Jefferson Institute for bioprocessing specialized teaching curriculum and training programs

VolitionRx and Gyros Protein Technologies awarded an aggregate $1 million+ Eurostars cash grant to collaborate on developing a lung cancer blood test

Mesa Labs acquires Gyros Protein Technologies

Gyros Protein Technologies introduces Gyrolab p24 Kit to support the cell and gene therapy market

Gyros Protein Technologies introduces Gyrolab E. coli HCP Kit for automated impurity analysis of biotherapeutics

Contact Us

Gyrolab® News

Gyrolab^® News